Dr. Celina Ingram, M.D.
What this data tells you about Dr. Ingram
Dr. Celina Ingram is a pathology - anatomic specialist in Austin, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Ingram performed 2,523 Medicare services across 881 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ingram received a total of $815 from 4 pharmaceutical and/or device companies across 4 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pathology - anatomic. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ingram is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Flow cytometry, additional marker | 1,281 | $18 | $62 |
| Tissue staining for diagnosis, additional | 206 | $62 | $251 |
| Special stained specimen slides to examine tissue including interpretation and report | 131 | $61 | $229 |
| Tissue pathology examination, moderate complexity | 113 | $54 | $212 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 111 | $300 | $1,150 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 95 | $63 | $239 |
| Tissue staining for diagnosis, initial | 65 | $74 | $287 |
| Blood smear interpretation by physician with written report | 62 | $18 | $63 |
| Bone marrow, smear interpretation | 58 | $53 | $196 |
| Preparation of tissue for examination by removing any calcium present | 56 | $15 | $59 |
| Cell examination of body fluid, smears | 52 | $52 | $191 |
| Pathology examination of tissue using a microscope, moderately high complexity | 52 | $62 | $416 |
| Flow cytometry technique for dna or cell analysis, first marker | 46 | $56 | $192 |
| Pathology examination of tissue using a microscope, moderately low complexity | 37 | $9 | $181 |
| Pathology examination of tissue using a microscope, limited examination | 25 | $3 | $38 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 21 | $61 | $276 |
| Cell examination of specimen, selective cellular enhancement technique | 18 | $21 | $175 |
| Microscopic genetic analysis of tissue, manual, initial procedure | 18 | $108 | $387 |
| Genetic sequencing localization, initial procedure | 16 | $129 | $511 |
| Genetic sequencing localization, each additional procedure | 15 | $104 | $392 |
| Pathology cytologic examination of specimen during surgery, initial site | 12 | $47 | $109 |
| Tissue culture for tumor disorders of bone marrow and blood cells | 11 | $141 | $431 |
| Chromosome analysis for genetic defects, count 15-20 cells | 11 | $123 | $376 |
| Interpretation and report of genetic testing | 11 | $25 | $94 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
Associated products mentioned in payments ›
The majority of payments (92%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ingram is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), with consulting-driven industry engagement in the top 13% of TX peers, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ingram experienced with flow cytometry, additional marker?
Does Dr. Ingram receive payments from pharmaceutical companies?
How do Dr. Ingram's costs compare to other pathology - anatomics in Austin?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology